Amgen Falters In Core Immunology Business, But Help Is On The Horizon

2023 Guidance Raised Even Before Deal Closing

 
• By Mandy Jackson
  
Asphalt road ground and mountain landscape at sunset
Amgen expects to close its Horizon buy in late June • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business